CAROL KAVANAUGH: Open Payments
NPI 1689649444 · ORLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$117 in 6 payments from 5 companies in 2025. Trend: 2023 $175 · 2024 $110 · 2025 $117
Food & beverage: $117
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Corcept Therapeutics | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $14 |
Products named: GVOKE HYPOPEN, BREZTRI, Korlym, EVENITY, VRAYLAR.
Industry payments across CA — which companies pay providers there.
